BioNTech Announces First Quarter Financial Results and Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
BioNTech SE (BNTX) Reports Q1 EPS of EUR14.24, Reiterates FY22 Guidance
May 9, 2022 6:04 AM EDTBioNTech SE (NASDAQ: BNTX) reported Q1 EPS of EUR14.24. Revenue for the quarter came in at EUR6.4 billion.
The company reiterated COVID-19 2022 vaccine revenue guidance of 13 billion to 17 billion.
For earnings history and earnings-related data on BioNTech SE (BNTX) click here.
... More